Patients are in favour of personalised genetic testing, according to a new study. Research by the Scripps Translational Science Institute found that most people are in favour of the testing, which can predict whether patients are likely to contract conditions such as Alzheimer's disease, diabetes, glaucoma and cancer. Despite critics' protests against the practise, participants were found to experience no distress as a consequence of the test results. Many companies have offered genetic testing for years, by analysing DNA to come up with a risk report that details the chances of an individual developing certain illnesses. Study author Dr Eric Topol told the Associated Press: "We don't give consumers enough credit for the fact they can handle this type of information load about themselves." In other news, scientists from Scripps Research Institute have used synthetic peptoids to identify antibodies in the blood that increase when an individual has a certain disease. These findings could lead to a blood test to detect Alzheimer's, potentially revolutionising diagnosis of the condition.Find the nearest Barchester nursing home.